Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nature Biotechnology|June 5, 2019
Gene editing for immune cell therapiesStefanie R Bailey, Marcela V Maus
The Journal of Clinical Investigation|January 2, 2026
Fanning the flames: IFN-γ fuels CAR-T inflammation and cytopeniaStefanie R Bailey, Marcela V Maus
Transplantation|January 4, 2017
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A TherapyPeng Zhu, Stefanie R Bailey, Biao Lei, et al.
European Journal of Immunology|December 31, 2022
Four challenges to CAR T cells breaking the glass ceilingStefanie R Bailey, Trisha R Berger, Charlotte Graham, et al.
Oncology Reviews|August 29, 2019
Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapyJacob S Bowers, Stefanie R Bailey, Mark P Rubinstein, et al.
Frontiers in Immunology|July 3, 2014
Th17 cells in cancer: the ultimate identity crisisStefanie R Bailey, Michelle H Nelson, Richard A Himes, et al.
Cell Death & Disease|April 13, 2023
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cellsAlexandra L Pourzia, Michael L Olson, Stefanie R Bailey, et al.
Cellular & Molecular Immunology|March 23, 2018
When worlds collide: Th17 and Treg cells in cancer and autoimmunityHannah M Knochelmann, Connor J Dwyer, Stefanie R Bailey, et al.
JCI Insight|March 15, 2017
Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansionJacob S Bowers, Michelle H Nelson, Kinga Majchrzak, et al.
Cancer Immunology, Immunotherapy : CII|January 31, 2016
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicKinga Majchrzak, Michelle H Nelson, Stefanie R Bailey, et al.
Pageof 4